TickerFactsScreenerDevelopers

Tvardi Therapeutics, Inc. (TVRD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$47.38M2017: -$54.83M2018: -$22.30M2019: -$109.22M2020: -$5.49M2021: -$60.09M2022: -$78.73M2023: -$92.08M2024: -$18.30M2025: -$23.50M-$23.50M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$23.50M-28.4%
2024-$18.30M+80.1%
2023-$92.08M-17.0%
2022-$78.73M-31.0%
2021-$60.09M-995.1%
2020-$5.49M+95.0%
2019-$109.22M-389.8%
2018-$22.30M+59.3%
2017-$54.83M-15.7%
2016-$47.38M—